343
Views
50
CrossRef citations to date
0
Altmetric
Original Research

Factors associated with appropriate inhaler use in patients with COPD – lessons from the REAL survey

, , , , &
Pages 695-702 | Published online: 26 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (16)

Xin Tan, Shanling Liu, Li Huang, Ying Wu, Long Wen, Jiheng Liu, Yuling Tang & Xiaohui Liu. (2023) Correlation Analysis of the Therapy Adherence to Long-Acting Inhalers Among Patients with Stable COPD. Patient Preference and Adherence 17, pages 1467-1475.
Read now
Gema Requena, Victoria Banks, Alexandrosz Czira, Robert Wood, Theo Tritton, Rosie Wild, Chris Compton & Afisi S Ismaila. (2023) Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β2-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 231-245.
Read now
Marika T Leving, Job FM van Boven, Sinthia Z Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Marina García Pardo, Asparuh Gardev, Radosław Gawlik, Iris van der Ham, Elisabeth Sophia Hartgers-Gubbels, Ymke Janse, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David B Price, Miguel Roman-Rodríguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar S Usmani & Janwillem H Kocks. (2022) Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2401-2415.
Read now
Yi-Han Hsiao, Ching-Min Tseng, Chau-Chyun Sheu, Hsin-Yi Wang, Hsin-Kuo Ko, Kang-Cheng Su, Chi-Wei Tao, Ming-Ju Tsai & Yen-Fu Chen. (2022) Shared Decision-Making Facilitates Inhaler Choice in Patients with Newly-Diagnosed Chronic Obstructive Pulmonary Disease: A Multicenter Prospective Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2067-2078.
Read now
Yating Peng, Jiaxi Duan, Xin Li, Yuqin Zeng, Zijing Zhou, Minghua Deng, Ruoyun Ouyang, Yan Chen, Shan Cai & Ping Chen. (2021) Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2697-2706.
Read now
Rachel Pullen, Marc Miravitlles, Anita Sharma, Dave Singh, Fernando Martinez, John R Hurst, Luis Alves, Mark Dransfield, Rongchang Chen, Shigeo Muro, Tonya Winders, Christopher Blango, Hana Muellerova, Frank Trudo, Paul Dorinsky, Marianna Alacqua, Tamsin Morris, Victoria Carter, Amy Couper, Rupert Jones, Konstantinos Kostikas, Ruth Murray & David B Price. (2021) CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2301-2322.
Read now
Joanne Sloots, Mirthe Bakker, Job van der Palen, Michiel Eijsvogel, Paul van der Valk, Gerard Linssen, Clara van Ommeren, Martijn Grinovero, Monique Tabak, Tanja Effing & Anke Lenferink. (2021) Adherence to an eHealth Self-Management Intervention for Patients with Both COPD and Heart Failure: Results of a Pilot Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2089-2103.
Read now
Anne Tschacher, Cordula Cadus, Sebastian Schildge, Jens Peter Diedrich, Prashant N. Chhajed, Anne B. Leuppi-Taegtmeyer & Jörg Daniel Leuppi. (2021) Switching COPD patients from the disposable to the new reusable Respimat soft mist inhaler: a real-world study from Switzerland. Current Medical Research and Opinion 37:11, pages 2019-2033.
Read now
Kaho Akimoto, Kuniaki Hirai, Tomohiro Matsunaga, Keisuke Kaneko, Hatsuko Mikuni, Tomoko Kawahara, Tomoki Uno, Akiko Fujiwara, Yoshito Miyata, Shin Ohta, Tetsuya Homma, Hideki Inoue, Fumihiro Yamaguchi, Sojiro Kusumoto, Shintaro Suzuki, Akihiko Tanaka & Hironori Sagara. (2020) The Relationship Between the “Adherence Starts with Knowledge-20” Questionnaire and Clinical Factors in Patients with COPD: A Multi-Center, Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3201-3211.
Read now
Sahar Mansoor, Zaid Obaida, Lorna Ballowe, Amanda R Campbell, James T Patrie, Timothy D Byrum & Yun M Shim. (2020) Clinical Impact of Multidisciplinary Outpatient Care on Outcomes of Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 33-42.
Read now
Erminia Ridolo, Irene Pellicelli, Bruna Gritti & Cristoforo Incorvaia. (2019) Patient-reported outcomes and considerations in the management of COPD: focus on indacaterol/glycopyrronium bromide. Patient Preference and Adherence 13, pages 145-150.
Read now
Holly McCabe, Brian Godman, Amanj Kurdi, Katie Johnston, Sean MacBride-Stewart, Janey Lennon, Simon Hurding, Marion Bennie & Alec Morton. (2019) Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications. Expert Review of Respiratory Medicine 13:7, pages 679-689.
Read now
A Duarte-de-Araújo, P Teixeira, V Hespanhol & J Correia-de-Sousa. (2019) COPD: misuse of inhaler devices in clinical practice. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1209-1217.
Read now
Helgo Magnussen, Beatrix Fyrnys & Roland Greguletz. (2019) Genuair®/Pressair® Inhaler in COPD: The Patient Perspective. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 196-205.
Read now
David B Price, Sen Yang, Simon Wan Yau Ming, Antony Hardjojo, Claudia Cabrera, Andriana I Papaioannou, Stelios Loukides, Vicky Kritikos, Sinthia Z Bosnic-Anticevich, Victoria Carter & Paul M Dorinsky. (2018) Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3937-3946.
Read now

Articles from other publishers (34)

Tamas Erdelyi, Zsofia Lazar, Árpád Farkas, Peter Furi, Attila Nagy & Veronika Müller. (2023) Modeling of pulmonary deposition of agents of open and fixed dose triple combination therapies through two different low-resistance inhalers in COPD: a pilot study. Frontiers in Medicine 10.
Crossref
P. Barnestein-Fonseca, VM. Cotta-Luque, VP. Aguiar-Leiva, J. Leiva-Fernández, Francisco Martos-Crespo & F. Leiva-Fernández. (2023) The importance of reminders and patient preferences to improve inhaler technique in older adults with COPD. Frontiers in Pharmacology 13.
Crossref
Sorin Bivolaru & Ancuţa Constantin. (2023) The Impact of Technical Skills and Education on Exacerbations, Adherence to Treatment and the Choice of Inhaler Device in Patients with COPD. Internal Medicine 20:1, pages 27-41.
Crossref
Jacqueline O’Toole, Meera Krishnan, Kristin Riekert & Michelle N. Eakin. (2022) Understanding barriers to and strategies for medication adherence in COPD: a qualitative study. BMC Pulmonary Medicine 22:1.
Crossref
A. Di Filippo, S. Perna, A. Pierantozzi, F. Milozzi, F. Fortinguerra, N. Caranci, L. Moro, N. Agabiti, V. Belleudi, G. Cesaroni, A. Nardi, T. Spadea, R. Gnavi & F. Trotta. (2022) Socio-economic inequalities in the use of drugs for the treatment of chronic diseases in Italy. International Journal for Equity in Health 21:1.
Crossref
Annika Lindh, Kersti Theander, Mats Arne, Karin Lisspers, Lena Lundh, Hanna Sandelowsky, Björn Ställberg, Elisabeth Westerdahl & Ann-Britt Zakrisson. (2022) One additional educational session in inhaler use to patients with COPD in primary health care – A controlled clinical trial. Patient Education and Counseling 105:9, pages 2969-2975.
Crossref
Thomas M. Siler, Renu Jain, Kathryn Collison, Raj Sharma, Laura Sutton, Jamie Rees & David I. Bernstein. (2022) Correct use and ease-of-use of placebo ELLIPTA dry-powder inhaler in adult patients with chronic obstructive pulmonary disease. PLOS ONE 17:8, pages e0273170.
Crossref
Janwillem W. H. Kocks, Hans Wouters, Sinthia Bosnic-Anticevich, Joyce van Cooten, Jaime Correia de Sousa, Biljana Cvetkovski, Richard Dekhuijzen, Lars Dijk, Evgeni Dvortsin, Marina Garcia Pardo, Asparuh Gardev, Radosław Gawlik, Iris van Geer - Postmus, Iris van der Ham, Marten Harbers, Alberto de la Hoz, Ymke Janse, Marjan Kerkhof, Federico Lavorini, Tiago Maricoto, Jiska Meijer, Boyd Metz, David Price, Miguel Roman-Rodriguez, Kirsten Schuttel, Nilouq Stoker, Ioanna Tsiligianni, Omar Usmani & Marika T. Leving. (2022) Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers. npj Primary Care Respiratory Medicine 32:1.
Crossref
Sarah Serhal, Bandana Saini, Sinthia Bosnic-Anticevich, Ines Krass, Lynne Emmerton, Bonnie Bereznicki, Luke Bereznicki, Naomi Weier, Bernadette Mitchell, Frances Wilson, Zeeta Bawa, Bronwen Wright, Kiara Wilson, Rebecca Segrott, Marsha Gomez & Carol Armour. (2022) A Multi-Mode Education Program to Enhance Asthma Care by Pharmacists. American Journal of Pharmaceutical Education 86:4, pages 8633.
Crossref
Marika T. Leving, Janwillem Kocks, Sinthia Bosnic-Anticevich, Richard Dekhuijzen & Omar S. Usmani. (2022) Relationship between Peak Inspiratory Flow and Patient and Disease Characteristics in Individuals with COPD—A Systematic Scoping Review. Biomedicines 10:2, pages 458.
Crossref
Constança Monteiro, Tiago Maricoto, Filipe Prazeres, Pedro Augusto Simões & José Augusto Simões. (2022) Determining factors associated with inhaled therapy adherence on asthma and COPD: A systematic review and meta-analysis of the global literature. Respiratory Medicine 191, pages 106724.
Crossref
Joachim Schmidt. 2022. Physiotherapie bei chronisch-obstruktiven Atemwegs- und Lungenerkrankungen. Physiotherapie bei chronisch-obstruktiven Atemwegs- und Lungenerkrankungen 303 307 .
Rudi Peché, Darush Attar-Zadeh, Jane Scullion & Janwillem Kocks. (2021) Matching the Inhaler to the Patient in COPD. Journal of Clinical Medicine 10:23, pages 5683.
Crossref
Jin Sun Kim, Nader Hashweh, Hannah Li, Salik Choudhary, Sadashiv Santosh & Edward Charbek. (2021) Effectiveness of one-on-one coaching in improving pressurized metered dose inhaler (pMDI) technique among COPD patients: a prospective clinical study. BMC Pulmonary Medicine 21:1.
Crossref
Masato Muraki, Yuki Kunita, Ken Shirahase, Ryo Yamazaki, Soichiro Hanada, Hirochiyo Sawaguchi & Yuji Tohda. (2021) A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. BMC Pulmonary Medicine 21:1.
Crossref
Bruno Sposato, Elisa Petrucci, Andrea Serafini, Fabio Lena, Leonardo Gianluca Lacerenza, Andrea Montagnani, Massimo Alessandri, Alberto Cresti, Raffaele Scala, Paola Rogliani, Alberto Ricci, Antonio Perrella & Marco Scalese. (2021) Which LABA/LAMA should be chosen in COPD patients in real life?. Pulmonary Pharmacology & Therapeutics 71, pages 102076.
Crossref
Marika Leving, Hans Wouters, Alberto de la Hoz, Sinthia Bosnic-Anticevich, Richard Dekhuijzen, Asparuh Gardev, Federico Lavorini, Jiska Meijer, David Price, Miguel Román Rodríguez, Ioanna Tsiligianni, Omar Usmani, Birgit Wijnsma & Janwillem Kocks. (2021) Impact of PIF, Inhalation Technique and Medication Adherence on Health Status and Exacerbations in COPD: Protocol of a Real-World Observational Study (PIFotal COPD Study). Pulmonary Therapy 7:2, pages 591-606.
Crossref
Myriam Gagné, Christine Hamel, Sophie Lauzier, Sara-Edith Penney, Jean Bourbeau, Jocelyne Moisan & Louis-Philippe Boulet. (2021) Comparative educational outcomes of an active versus passive learning continuing professional development activity on self-management support for respiratory educators: A non-randomized controlled mixed-methods study. Nurse Education in Practice 57, pages 103256.
Crossref
Rani Sauriasari, Raiza Aulia Madani, Anna Rozaliyani & Dodi Sudiana. (2021) The effect of repeated education using live demonstrations and videos of how to use inhalation drugs on quality of life for COPD patients. Heliyon 7:9, pages e07870.
Crossref
Sarah E. Petite, Michael W. Hess & Herbert Wachtel. (2020) The Role of the Pharmacist in Inhaler Selection and Education in Chronic Obstructive Pulmonary Disease. Journal of Pharmacy Technology 37:2, pages 95-106.
Crossref
Muhammet Raşit Aydın, Yusuf Aydemir, Abdülkadir Aydın & Hasan Çetin Ekerbiçer. (2021) The effect of video presentation showed in the outpatient clinic waiting area on the success of inhaler device use in chronic respiratory diseases. Heart & Lung 50:2, pages 323-328.
Crossref
Lindsay G S BengtsonTim BancroftCraig SchillingAmi R BuikemaRichard H Stanford. (2021) Development and validation of a drug adherence index for COPD. Journal of Managed Care & Specialty Pharmacy 27:2, pages 198-209.
Crossref
E. López-Pintor, J. Grau, I. González, MC Bernal-Soriano, J.A. Quesada & B. Lumbreras. (2021) Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respiratory Medicine 176, pages 106280.
Crossref
Jens Schreiber, Tina Sonnenburg & Eva Luecke. (2020) Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates. BMC Pulmonary Medicine 20:1.
Crossref
Maurizio Mongelli, Vanessa Orani, Enrico Cambiaso, Ivan Vaccari, Alessia Paglialonga, Fulvio Braido & Chiara Eva Catalano. (2020) Challenges and Opportunities of IoT and AI in Pneumology. Challenges and Opportunities of IoT and AI in Pneumology.
Suhaj Abdulsalim, Mazhuvancherry Kesavan Unnikrishnan, Mohan K. Manu, Saud Alsahali, Alian A. Alrasheedy, Antony P. Martin, Brian Godman & Abubakr A. Alfadl. (2019) Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India. PharmacoEconomics - Open 4:2, pages 331-342.
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R. Celli. (2020) Inhaler device feature preferences among patients with obstructive lung diseases. Medicine 99:25, pages e20718.
Crossref
Malene Skorstengaard, Julie Suhr & Elsebeth Lynge. (2019) Condom use to enhance regression of cervical intraepithelial neoplasia: study protocol for a randomized controlled trial. Trials 20:1.
Crossref
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi & David Price. (2019) Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Pulmonary Therapy 5:1, pages 23-41.
Crossref
Chau Ngo, Dung Phan, Giap Vu, Phu Dao, Phuong Phan, Hanh Chu, Long Nguyen, Giang Vu, Giang Ha, Tung Tran, Bach Tran, Carl Latkin, Cyrus Ho & Roger Ho. (2019) Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam. International Journal of Environmental Research and Public Health 16:2, pages 185.
Crossref
Federico Lavorini, Christer Janson, Fulvio Braido, Georgios Stratelis & Anders Løkke. (2019) What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape. Therapeutic Advances in Respiratory Disease 13, pages 175346661988453.
Crossref
A. Duarte-de-Araújo, P. Teixeira, V. Hespanhol & J. Correia-de-Sousa. (2019) Teaching inhalation technique in COPD outpatients: Can a sustained improvement be achieved?. Pulmonology 25:1, pages 53-55.
Crossref
A. A. Vizel & I. Yu. Vizel. (2018) 12-Hour fixed-dose combination of andrenergic agonist and cholinergic antagonist in a new administration device: analytical review. Medical Council:15, pages 116-122.
Crossref
Katarzyna Luczak-Wozniak, Marta Dabrowska, Izabela Domagala, Marta Miszczuk, Wojciech Lubanski, Andrzej Leszczynski & Rafal Krenke. (2018) Mishandling of pMDI and DPI inhalers in asthma and COPD – Repetitive and non-repetitive errors. Pulmonary Pharmacology & Therapeutics 51, pages 65-72.
Crossref